How many investments has BOLD Longevity made?

BOLD Longevity has 11 tracked investments, 1 of which have exited.

What stage does BOLD Longevity invest at?

BOLD Longevity invests at the Growth stage.

What sectors does BOLD Longevity focus on?

BOLD Longevity focuses on AI & Machine Learning, Biotech, Healthtech, Longevity.

Where is BOLD Longevity located?

BOLD Longevity is headquartered in Boston, US.

Does BOLD Longevity lead rounds?

BOLD Longevity typically participates in rounds rather than leading them.

Who does BOLD Longevity co-invest with?

BOLD Longevity most often shares deals with Bold Capital Partners, Gaingels, Draper Associates, among 114 tracked co-investors.

BOLD Longevity

Growth equityActively deployingoperating company · company profile

Boston · Growth · 10 people tracked

Also known as BLG ADVISOR LLC

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into BOLD Longevity

Paths you didn't know you had: your email and LinkedIn already hold routes to the BOLD Longevity team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict

Investment thesis

BOLD Longevity Growth focuses on growth- and scaling-stage biotechnology companies that target the root causes of aging and age-related diseases. It backs platform technologies delivering large efficiency and safety improvements (5-10x) that reshape medical practice and make treatments more affordable and accessible. The fund co-invests alongside major biotech VC funds and large pharmaceutical companies, contributing capital, experienced partners, and a network of scientific and venture advisors. Its aim is to support companies changing how medicine is practiced and how diseases are diagnosed and treated, enabling healthy human life extension across areas such as gene editing, AI-driven drug discovery, and AI-powered diagnostics.

Invests inAI & Machine Learning Biotech Healthtech Longevity Boston Global United States

Source: firm website, verified Aug 18, 2026.

Leave your own feedback

Stage

Growth

Boston, Massachusetts, US

Leads rounds

Follows

Instruments

Equity

Founded

2023

Private fund assets

$71.3M

VC funds

Tracked investments

Unicorns

IPOs

Team · 10 people

from the firm's website & public directories

Peter H. Diamandis· Co-Founder & Partner· Santa Monica, Californiain 𝕏

Entrepreneur, author, and speaker; founder and executive chairman of the XPRIZE Foundation and founder of Singularity University. He co-founds ventures across longevity, space, and venture capital and holds degrees from MIT and Harvard.

Sergey Young· Co-Founder· Abu Dhabi, Abu Dhabi Emirate, United Arab Emiratesin 𝕏

Sergey Young is a longevity investor with over 20 years of investment experience, backing startups at the intersection of AI, longevity, and biotechnology. He co-founded the BOLD Longevity Growth (BLG) fund, focused on making longevity innovations more accessible and affordable. He co-created and sponsored XPRIZE Healthspan, a $101M competition on reversing human aging, and authored the bestselling book "The Science and Technology of Growing Young." He holds a diploma in Business Administration from Warwick Business School and degrees in Chemical Engineering and Economics.

sy@blg.vc

Teymour Boutros-Ghali· Co-Founder & Managing Partner· Santa Monica, California, United Statesin

A co-founder and managing partner at BOLD with over 30 years of investing and entrepreneurial experience. Previously a GP at Monitor Ventures and VP at Time Inc. Ventures, he led three companies through acquisitions. He holds a Cambridge EE degree and an MIT PhD.

Avetik Arakelian· General Partner

Avik Arakelian· Partner & Head of Investments· United Statesin

Brings 10+ years of PE and VC investment experience in biotech and health tech, having led or advised investments in more than 25 biotech and longevity companies spanning gene editing, AI drug discovery, and diagnostics. Previously worked at PwC and KPMG.

aa@blg.vc

Kris Verburgh· Partner & Head of Science· London, England, United Kingdomin

A medical doctor, author and researcher specialized in aging and longevity who authored the bestselling 'The Longevity Code' and created the field of nutrigerontology. He is a researcher at the ECCO Institute at the Free University Brussels.

kv@blg.vc

Will Borthwick· Principal, BOLD Capital· Los Angeles Metropolitan Areain

A principal at BOLD Capital with 10+ years of experience in investment banking, private equity and venture capital, having worked at Marlin Equity Partners and Morgan Stanley. His expertise spans AI/ML, clinical trial optimization and diagnostics.

Gunner Hardy· Senior Associate· New York, New York, United Statesin

An investment professional with experience in banking, startup advisory and genetics research. He previously worked at BofA Merrill Lynch, the World Bank and EBRD, was an analyst at Conscience VC, and worked with VITA DAO.

gh@blg.vc

Helen McBride· Operating Partner, BOLD Capital· Los Angeles Metropolitan Areain

Brings 20+ years in healthcare and life sciences, including 13+ years at Amgen and a role at TORL Biotherapeutics. She previously led healthcare investing at Fund@Caltech and holds a PhD in Oncological Sciences.

Sun Altbach· Senior Scientific Advisor· Boston, Massachusetts, United Statesin

A biopharmaceutical executive with over 25 years of experience, having worked at Biogen, Genzyme and Shire, and served as founding CEO of PIC Therapeutics. She holds a BA from Smith College and an MBA from MIT.

Founder mafia

4 people who came through BOLD Longevity went on to found or lead other companies.

Peter H. DiamandisCo-Founder & PartnerFounded Abundance360 +2 Teymour Boutros-GhaliCo-Founder & Managing PartnerFounded All Business Kris VerburghPartner & Head of ScienceFounded NOVOS Sun AltbachSenior Scientific AdvisorFounded Pic Therapeutics

What they invest in

from 10 of 11 portfolio companies

Healthtech ×8AI & Machine Learning ×6Biotech ×5Digital Health ×4Deep Tech ×3Medical Devices ×3Hardware ×2Longevity ×1

HQs:United States×10

Who they back

founder profiles across 10 portfolio companies

10%

solo founders

1 of 10 mapped founding teams

50%

repeat founders

of 16 founders with career history

Founding team size:solo founder×12 founders×33 founders×14+ founders×5

Where their founders studiedfrom 13 founders with education data

Stanford University ×3Massachusetts Institute of Technology ×2University of Cambridge ×2University of Washington ×2

What their founders studiedfrom 16 founders with field-of-study data

Computer Science ×6Life Sciences ×6Engineering ×4Medicine ×3Business & Management ×2Humanities ×2Mathematics & Statistics ×2

Investments · 11 tracked

founders shown can be your intro path

4D Molecular Therapeutics4dmoleculartherapeutics.com inNASDAQ: FDMT

4DMT is a late-stage biotechnology company that develops gene delivery systems and genetic therapeutics targeting specific tissue types for various diseases.

BiotechHealthtechEmeryville, US

David Kirn(Executive Officer, Director)in David Schaffer(Director)inTheresa Janke(Executive Officer)in

BoardSharon Tetlow(Director)Margi McLoughlin(Director)

Co-investorsAmzak Health Berkeley Catalyst Chiesi Ventures Pappas Capital Pfizer Venture Investments Ridgeback Capital +7 more

Aqtualaqtual.com in

Aqtual is a precision medicine company led by experienced healthcare professionals, entrepreneurs, and technical experts.

AI & Machine LearningHealthtechMedical DevicesHayward, US

Diana Abdueva(Founder)inRichard Rava(Founder)

Co-investorsBold Capital Partners Genoa Ventures Manta Ray Ventures

BigHat Biosciencesbighatbio.com in 𝕏

Big Hat Bio develops therapeutics under development across multiple programs.

AI & Machine LearningBiotechDeep TechSan Francisco, US

Peyton Greenside(Founder)in Mark DePristo(Founder)inMark DePristo Peyton Greenside(Founder)Theresa Tribble(Founder)

Board Francisco Gimenez(Director)inSteve Kafka(Director)

Co-investors8VC Andreessen Horowitz Flucas Ventures GRIDS Capital Intermountain Health Merck Global Health Innovation Fund +12 more

Biolinqbiolinq.com in

Biolinq develops glucose-sensing technology based on micro-array biosensors for metabolic health monitoring, including continuous glucose monitoring.

BiotechDigital HealthHardwareHealthtechMedical DevicesSan Diego, US

Jared Tangney(Co-founder)inRich Yang(Co-founder)inEdward Kliphuis(Director)

Board Daniel Bradbury(Director)in Lana Ghanem(Director)

Co-investorsAlpha Wave Global RiverVest Venture Partners Able Partners Aphelion Capital Averin Capital Beyond Capital +7 more

Colossal Biosciencescolossal.com 𝕏

Capital Factory is an investment and advisory network that connects ambitious founders and operators with investors, advisors, and resources to support early-stage companies addressing significant challenges.

Deep TechSector AgnosticAustin, US

Ben Lamm(Founder)in Brian Beard(Executive Officer, Director)inBen Lamm George Church(Founder)George M. Church(Founder)

Board Tom Chi(Director)in

Co-investorsAt One Ventures Bold Capital Partners Breyer Capital Capital Factory Carnrite Ventures Climate Capital +18 more

Fountain Lifefountainlife.com in

Fountain Life is a private preventive health membership service that uses AI-guided diagnostics, physician-led interpretation, and restorative therapeutics to detect issues early and create personalized plans focused on healthspan and longevity.

AI & Machine LearningDigital HealthHealthtechLongevityOrlando, US

Anthony Robbins(Director)Robert Hariri, MD(Founding Partner)Peter H. Diamandis, MD(Co-Founder / Founding Partner)inWilliam K. Kapp, III, MD(Director)Dr. William Kapp(Co-Founder & CEO)Tony Robbins(Founding Partner)

Co-investorsBold Capital Partners Eos Venture Partners Limited PHD Ventures Seed Healthcare

Insilico Medicineinsilico.com in 𝕏Sep 2019

Insilico Medicine uses artificial intelligence to discover and develop new drugs, operating an AI-driven platform for pharmaceutical research and development.

AI & Machine LearningBiotechDigital HealthHealthtechHong Kong, US

Aleksandrs Zavoronkovs(Executive Officer, Director)Alex Zavoronkov(Director)Alex Zhavoronkov(Founder)inAlex Aliper(President)inFeng Ren(Chief Scientific Officer, Executive Director & Co-CEO)in

Board Nisa Leung(Director)in

Co-investorsLilly Asia Ventures OrbiMed Qiming Venture Partners Warburg Pincus Baidu Ventures Eight Roads Ventures +13 more

Ouraouraring.com

Oura Ring is a wearable smart ring that collects and analyzes 50+ personal health metrics to provide insights on sleep, fitness, and wellness for individual users.

HardwareHealthtechWellness & FitnessSan Francisco, US

Ashley Colley(Founder)Virpi Tuomivaara(Founder)in Tom Hale(CEO)inKari Kivela(Founder)Markku Koskela(Founder)Petteri Lahtela(Founder)

Co-investors125 Ventures A-Rod Corp Able Partners Alumni Ventures B37 Ventures Basecamp Fund +37 more

Propriopropriovision.com in 𝕏

Proprio develops Paradigm, an implant-agnostic surgical platform that provides intraoperative guidance and structured surgical data without requiring 3D imaging or mobile CT.

AI & Machine LearningHealthtechMedical DevicesSeattle, US

Gabriel Jones(Co-founder & CEO)in Samuel Browd(Co-founder)inJoshua Smith(Co-founder)inJames Youngquist(Co-founder)in

Co-investorsBold Capital Partners Cota Capital DCVC (Data Collective)Bird B. AG HTC Presence Capital +4 more

Verge Genomicsvergegenomics.com in 𝕏

Verge Labs builds AI models trained on multimodal human patient data to predict drug targets and patient populations for clinical development, primarily in neuroscience and central nervous system (CNS) disease.

AI & Machine LearningBiotechDeep TechDigital HealthHealthtechSan Francisco, US

Alice Zhang(CEO)in Jason Chen(Founder)inEmily Ripka(Vice President Product \u0026 Engineering)in Naveen Jain(Investor)inGeorge Spencer(Operations)

Co-investorsAgent Capital ALS Investment Fund Draper Associates Fitz Gate Ventures Great Oaks Venture Capital Karlin Ventures +28 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

4DMT

Exits · 1

1 IPOs

4D Molecular TherapeuticsNASDAQ: FDMT

Portfolio news

latest coverage across their companies

Colossal co-founder Ben Lamm raises $20M at $3.8B for AI that predicts how biology breaks — TFN

Colossal Biosciences · techfundingnews.com · Aug 21, 2026

Insilico Medicine Launches the Industry's First Drug Discovery and Development (DDD) Benchmark as a Service, to Evaluate Frontier AI and Foundation Models on Real-World Science - BioSpace

Insilico Medicine · biospace.com · Jul 30, 2026

Lilly Makes an Equity Investment in Oura, Supporting Oura’s Vision for More Connected Care - The Pulse Blog

Oura · ouraring.com · Jul 15, 2026

Tony Robbins and Peter Diamandis’ longevity company Fountain Life raises $18M

Fountain Life · finance.yahoo.com · Aug 13, 2025

Biolinq Announces Close of $100M Series C Financing to Advance Its Biowearable Platform for Metabolic Health - BioSpace

Biolinq · biospace.com · Apr 22, 2025

Frequently asked questions

How many investments has BOLD Longevity made?: BOLD Longevity has 11 tracked investments, 1 of which have exited.
What stage does BOLD Longevity invest at?: BOLD Longevity invests at the Growth stage.
What sectors does BOLD Longevity focus on?: BOLD Longevity focuses on AI & Machine Learning, Biotech, Healthtech, Longevity.
Where is BOLD Longevity located?: BOLD Longevity is headquartered in Boston, US.
Does BOLD Longevity lead rounds?: BOLD Longevity typically participates in rounds rather than leading them.
Who does BOLD Longevity co-invest with?: BOLD Longevity most often shares deals with Bold Capital Partners, Gaingels, Draper Associates, among 114 tracked co-investors.

Media · Podcasts & interviews

featuring the team

Mustafa Suleyman: The AGI Race Is Fake, Building Safe Superintelligence & the Agentic Economy | #216